LOGIN  |  REGISTER
Astria Therapeutics

Recent Insider Transactions - Immunovant (NASDAQ: IMVT)

Follow NASDAQ:IMVT Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ IMVT Immunovant
Geffner Michael / officer: Chief Medical Officer
04/24/2024
Sell
$28.90
3,261
$94K
141,616
NASDAQ IMVT Immunovant
Stout Jay S / officer: Chief Technology Officer
04/24/2024
Sell
$28.90
7,239
$209K
147,739
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
04/24/2024
Sell
$28.90
3,963
$115K
343,156
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
04/17/2024
Sell
$28.80
7,602
$219K
349,344
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
04/17/2024
Sell
$29.94
2,225
$67K
347,119
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
04/17/2024
Sell
$28.80
6,136
$177K
379,794
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
04/17/2024
Sell
$29.94
1,796
$54K
377,998
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
04/17/2024
Sell
$28.80
269
$8K
377,729
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
04/17/2024
Sell
$29.94
79
$2K
377,650
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
04/17/2024
Sell
$28.80
9,479
$273K
362,230
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
04/17/2024
Sell
$29.94
2,774
$83K
359,456
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
04/17/2024
Sell
$28.80
7,825
$225K
453,917
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
04/17/2024
Sell
$29.94
2,290
$69K
451,627
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
04/17/2024
Sell
$28.80
26,365
$759K
1.06M
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
04/17/2024
Sell
$29.94
7,714
$231K
1.05M
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
04/09/2024
Sell
$31.18
3,689
$115K
371,709
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
04/09/2024
Sell
$31.18
1,053
$33K
461,742
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
04/09/2024
Sell
$31.18
4,807
$150K
1.09M
NASDAQ IMVT Immunovant
Fromkin Andrew J. / director
04/02/2024
Buy
$30.78
4,690
$144K
4,690
NASDAQ IMVT Immunovant
Hughes Douglas J. / director
04/02/2024
Buy
$30.78
4,690
$144K
4,690
NASDAQ IMVT Immunovant
MIGAUSKY GEORGE V / director
04/02/2024
Buy
$30.78
4,690
$144K
4,690
NASDAQ IMVT Immunovant
Pande Atul / director
04/02/2024
Buy
$30.78
4,690
$144K
4,690
NASDAQ IMVT Immunovant
Torti Frank / director
04/02/2024
Buy
$30.78
50,167
$1.544M
50,167
NASDAQ IMVT Immunovant
Stout Jay S / officer: Chief Technology Officer
04/02/2024
Buy
$30.78
68,723
$2.115M
68,723
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
04/02/2024
Buy
$30.78
68,723
$2.115M
68,723
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
04/02/2024
Buy
$30.78
68,723
$2.115M
68,723
NASDAQ IMVT Immunovant
Geffner Michael / officer: Chief Medical Officer
04/02/2024
Buy
$30.78
68,723
$2.115M
68,723
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
04/02/2024
Buy
$30.78
68,723
$2.115M
68,723
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
04/02/2024
Buy
$30.78
68,723
$2.115M
68,723
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
04/02/2024
Buy
$30.78
200,667
$6.177M
200,667
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
02/22/2024
Sell
$36.15
2,930
$106K
320,420
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
02/22/2024
Sell
$36.15
2,134
$77K
301,968
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
02/22/2024
Sell
$36.15
2,221
$80K
330,952
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
02/22/2024
Sell
$36.15
2,146
$78K
407,817
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
02/22/2024
Sell
$36.15
13,454
$486K
931,231
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
01/26/2024
Sell
$37.91
2,981
$113K
304,148
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
01/26/2024
Sell
$38.45
46
$2K
304,102
NASDAQ IMVT Immunovant
Geffner Michael / officer: Chief Medical Officer
01/26/2024
Sell
$37.91
9,948
$377K
90,052
NASDAQ IMVT Immunovant
Geffner Michael / officer: Chief Medical Officer
01/26/2024
Sell
$38.45
153
$6K
89,899
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
01/18/2024
Sell
$41.03
424
$17K
333,173
NASDAQ IMVT Immunovant
Geffner Michael / officer: Chief Medical Officer*
01/17/2024
Sell
$18.06
150,000
$2.709M
0
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
01/11/2024
Sell
$41.64
2,681
$112K
324,184
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
01/11/2024
Sell
$42.43
834
$35K
323,350
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
01/05/2024
Sell
$38.59
1,297
$50K
409,963
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
01/05/2024
Sell
$38.59
3,824
$148K
944,685
NASDAQ IMVT Immunovant
Fromkin Andrew J. / director
12/01/2023
Sell
$38.78
3,941
$153K
97,067
NASDAQ IMVT Immunovant
Fromkin Andrew J. / director
12/01/2023
Sell
$39.81
3,636
$145K
93,431
NASDAQ IMVT Immunovant
Fromkin Andrew J. / director
12/01/2023
Sell
$40.46
4,773
$193K
88,658
NASDAQ IMVT Immunovant
Pande Atul / director
12/01/2023
Sell
$38.80
4,129
$160K
91,379
NASDAQ IMVT Immunovant
Pande Atul / director
12/01/2023
Sell
$39.82
3,374
$134K
88,005
NASDAQ IMVT Immunovant
Pande Atul / director
12/01/2023
Sell
$40.46
4,847
$196K
83,158
NASDAQ IMVT Immunovant
MIGAUSKY GEORGE V / director
12/01/2023
Sell
$38.79
4,200
$163K
118,308
NASDAQ IMVT Immunovant
MIGAUSKY GEORGE V / director
12/01/2023
Sell
$39.81
3,478
$138K
114,830
NASDAQ IMVT Immunovant
MIGAUSKY GEORGE V / director
12/01/2023
Sell
$40.46
5,022
$203K
109,808
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
11/22/2023
Sell
$32.75
15,601
$511K
949,125
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
11/22/2023
Sell
$33.52
616
$21K
948,509
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
11/22/2023
Sell
$32.75
3,901
$128K
327,019
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
11/22/2023
Sell
$33.52
154
$5K
326,865
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
11/22/2023
Sell
$32.75
3,141
$103K
411,384
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
11/22/2023
Sell
$33.52
124
$4K
411,260
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
11/22/2023
Sell
$32.75
3,141
$103K
333,721
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
11/22/2023
Sell
$33.52
124
$4K
333,597
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
11/22/2023
Sell
$32.75
3,128
$102K
307,253
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
11/22/2023
Sell
$33.52
124
$4K
307,129
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
10/25/2023
Sell
$34.66
4,107
$142K
310,381
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
10/19/2023
Sell
$36.80
530
$20K
336,862
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
10/10/2023
Sell
$36.92
4,557
$168K
330,920
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
10/05/2023
Sell
$35.54
296
$11K
415,964
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
10/05/2023
Sell
$36.39
1,439
$52K
414,525
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
10/05/2023
Sell
$35.54
894
$32K
969,071
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
10/05/2023
Sell
$36.39
4,345
$158K
964,726
NASDAQ IMVT Immunovant
Roivant Sciences Ltd. / director, 10 percent owner:
10/02/2023
Buy
$38.00
1.53M
$58.000M
79.81M
NASDAQ IMVT Immunovant
Roivant Sciences Ltd. / director, 10 percent owner:
10/02/2023
Buy
$38.00
4.47M
$170.000M
78.28M
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
08/30/2023
Sell
$21.97
50,866
$1.118M
975,873
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
08/30/2023
Sell
$22.48
5,908
$133K
969,965
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
08/24/2023
Sell
$20.30
12,285
$249K
314,489
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
08/24/2023
Sell
$20.89
1
$21
314,488
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
08/24/2023
Sell
$20.30
14,385
$292K
335,478
NASDAQ IMVT Immunovant
Barnett Eva Renee / officer: Chief Financial Officer
08/24/2023
Sell
$20.89
1
$21
335,477
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
08/24/2023
Sell
$20.30
12,332
$250K
416,261
NASDAQ IMVT Immunovant
Butchko Julia G. / officer: Chief Development Officer
08/24/2023
Sell
$20.89
1
$21
416,260
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
08/24/2023
Sell
$20.30
12,332
$250K
337,393
NASDAQ IMVT Immunovant
Macias William L. / officer: Chief Medical Officer
08/24/2023
Sell
$20.89
1
$21
337,392
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
08/14/2023
Sell
$21.34
91,744
$1.958M
1.04M
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
08/14/2023
Sell
$22.04
11,314
$249K
1.03M
NASDAQ IMVT Immunovant
Salzmann Peter / director, officer: Chief Executive Officer
08/07/2023
Sell
$21.73
101,339
$2.202M
1.13M
NASDAQ IMVT Immunovant
Levine Mark S. / officer: Chief Legal Officer
07/26/2023
Sell
$21.63
3,917
$85K
326,774

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous